Supernus Pharmaceuticals, Inc. (SUPN) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for SUPN. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 9,350,046 | $435M | INCREASED |
| State Street | 2,459,828 | $114M | INCREASED |
| Stephens Investment Management Group | 1,485,821 | $69M | INCREASED |
| Rice Hall James & Associates | 490,221 | $23M | INCREASED |
| Aberdeen Group | 453,206 | $21M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Jonathan Rubin (SVP, Chief Medical Officer) | AWARD | 750 | 2026-07-29 | |
| Padmanabh P. Bhatt (Sr. VP of IP, CSO) | AWARD | 2,500 | 2026-07-29 | |
| Frank Mottola (SVP, Chief Tech. Ops. Officer) | AWARD | 1,650 | 2026-07-29 | |
| Timothy C Dec (Senior Vice-President & CFO) | AWARD | 1,250 | 2026-07-29 | |
| Jack A. Khattar (President, CEO) | AWARD | 29,849 | 2026-07-29 |
Full institutional holdings, insider history, and congressional trades for Supernus Pharmaceuticals, Inc. on SentiSense.